| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The FASEB Journal, Vol 7, 944-950, Copyright © 1993 by The Federation of American Societies for Experimental Biology
RESEARCH COMMUNICATIONS |
Y Sun, Z Dong, K Nakamura and NH Colburn
Cell Biology Section, Frederick Cancer Research and Development Center, Maryland 21702-1201.
Mutational inactivation of p53, a tumor suppressor gene, is the most common genetic alteration found in human cancer. Most mutated p53s either lose tumor suppressor function or gain oncogenic activity. We recently reported the detection of a heterozygous point mutation of p53 at codon 280 in nasopharyngeal carcinoma (NPC) (1), a high-incidence malignancy in southern China and southeast Asia. Given its heterozygous state, in which both wild-type and mutated p53 gene were expressed, p53- thr280 should function dominantly in the presence of the wild-type form if it is to play a role in nasopharynx carcinogenesis. We tested this dominance hypothesis in the cells of two model systems: 1) human Saos-2 cells lacking endogenous p53, and 2) mouse JB6 tumor promotion- resistant cells (P-) expressing endogenous wild-type p53. The results showed dosage-dependent dominance of p53-thr280 in controlling WT p53- driven transcriptional activity; in governing cell growth; and in progressing P- phenotype to tumor promotion-sensitive (P+) phenotype. This dominant negative effect was seen at a 1:1 (WT:MU) ratio and was more striking at a ratio of 1:3. A model is proposed to explain the dominant negative effect of mutant p53. We conclude from this study that p53-thr280 is likely to be dominant in the heterozygous state found in NPC and that this dominant-negative mutated p53 may contribute to the genesis of NPC or of other carcinomas in which both mutant and wild-type p53 are expressed.
This article has been cited by other articles:
|
|
 |
|
  H.-S. Kim, S. Vijayakumar, M. Reger, J. C. Harrison, J. E. Haber, C. Weil, and J. H. J. Petrini Functional Interactions Between Sae2 and the Mre11 Complex Genetics, February 1, 2008; 178(2): 711 - 723. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Xia, A. Paik, and J. J. Li p53 Activation in Chronic Radiation-Treated Breast Cancer Cells: Regulation of MDM2/p14ARF Cancer Res., January 1, 2004; 64(1): 221 - 228. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Li, P. Jiang, M. Robinson, T. S. Lawrence, and Y. Sun AMPK-{beta}1 subunit is a p53-independent stress responsive protein that inhibits tumor cell growth upon forced expression Carcinogenesis, May 1, 2003; 24(5): 827 - 834. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Huang, M. Tan, M. Gosink, K. K. W. Wang, and Y. Sun Histone Deacetylase 5 Is Not a p53 Target Gene, But Its Overexpression Inhibits Tumor Cell Growth and Induces Apoptosis Cancer Res., May 1, 2002; 62(10): 2913 - 2922. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Yan, H. Wang, and D. D. Boyd ATF3 Represses 72-kDa Type IV Collagenase (MMP-2) Expression by Antagonizing p53-dependent trans-Activation of the Collagenase Promoter J. Biol. Chem., March 22, 2002; 277(13): 10804 - 10812. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. V. Blagosklonny, P. Giannakakou, L. Y. Romanova, K. M. Ryan, K. H. Vousden, and T. Fojo Inhibition of HIF-1- and wild-type p53-stimulated transcription by codon Arg175 p53 mutants with selective loss of functions Carcinogenesis, June 1, 2001; 22(6): 861 - 867. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Liu, N. Chen, A. Kaji, A. M. Bode, C. A. Ryan, and Z. Dong Proteinase inhibitors I and II from potatoes block UVB-induced AP-1 activity by regulating the AP-1 protein compositional patterns in JB6 cells PNAS, April 25, 2001; (2001) 101116298. [Abstract] [Full Text]
|
|
|
|
|
|
M. Tan, Y. Wang, K. Guan, and Y. Sun PTGF-beta , a type beta transforming growth factor (TGF-beta ) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-beta signaling pathway PNAS, January 4, 2000; 97(1): 109 - 114. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Sun, Y. Sun, L. Wenger, J. L. Rutter, C. E. Brinckerhoff, and H. S. Cheung p53 Down-regulates Human Matrix Metalloproteinase-1 (Collagenase-1) Gene Expression J. Biol. Chem., April 23, 1999; 274(17): 11535 - 11540. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Tan, S. Li, M. Swaroop, K. Guan, L. W. Oberley, and Y. Sun Transcriptional Activation of the Human Glutathione Peroxidase Promoter by p53 J. Biol. Chem., April 23, 1999; 274(17): 12061 - 12066. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ding, Z. Dong, F. Chen, D. Pack, W.-Y. Ma, J. Ye, X. Shi, V. Castranova, and V. Vallyathan Asbestos Induces Activator Protein-1 Transactivation in Transgenic Mice Cancer Res., April 1, 1999; 59(8): 1884 - 1889. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Huang, W.-Y. Ma, C. A. Ryan, and Z. Dong Proteinase inhibitors I and II from potatoes specifically block UV-induced activator protein-1 activation through a pathway that is independent of extracellular signal-regulated kinases, c-Jun N-terminal kinases, and P38 kinase PNAS, October 28, 1997; 94(22): 11957 - 11962. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-K. Hwang and C.-T. Lin Co-localization of Endogenous and Exogenous p53 Proteins in Nasopharyngeal Carcinoma Cells J. Histochem. Cytochem., July 1, 1997; 45(7): 991 - 1004. [Abstract] [Full Text]
|
|
|
|
|
|
G. Liu, N. Chen, A. Kaji, A. M. Bode, C. A. Ryan, and Z. Dong Proteinase inhibitors I and II from potatoes block UVB-induced AP-1 activity by regulating the AP-1 protein compositional patterns in JB6 cells PNAS, May 8, 2001; 98(10): 5786 - 5791. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
